Bristol-Myers Squibb (BMY) stock forecast for 2022. Forecast tables and graphs.

Bristol-Myers Squibb (BMY) stock forecast for 2022

The forecast has been updated: October 27, 2021 5:51


Bristol-Myers stock price online today

Analyst Target Price

74.63

Dividend Date

01.11.2021

Ex Dividend Date

30.09.2021

Last Split Factor

1000000:95

Last Split Date

07.08.2001

Should you buy or sell Bristol-Myers stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Bristol-Myers stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $74.63 target price for Bristol-Myers stock stock.

Today 200 Day Moving Average is the resistance level (64.73 $).

50 Day Moving Average is the resistance level (59.83 $).




BMY Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 61.57 60.52 63.63 4.90 %
Feb 60.18 57.99 60.87 4.73 %
Mar 61.34 59.55 62.75 5.11 %
Apr 61.54 60.19 64.11 6.12 %
May 63.57 61.79 64.97 4.90 %
Jun 63.22 61.69 64.20 3.90 %
Jul 61.52 60.00 63.89 6.09 %
Aug 58.27 57.40 60.64 5.34 %
Sep 55.42 53.86 57.61 6.51 %
Oct 53.59 52.11 55.24 5.66 %
Nov 53.68 51.64 54.77 5.71 %
Dec 55.48 54.44 57.61 5.51 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Bristol-Myers stock.


Bristol-Myers overview

Bristol-Myers Address

430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US

Market Capitalization

129 415 684 000 $

EBITDA

18 836 001 000

PE Ratio

None

PEG Ratio

13.71

Dividend Per Share

1.92

Dividend Yield

0.0332

EPS

-2.264

Quarterly Earnings Growth YOY

-0.011

Quarterly Revenue Growth YOY

0.155

Trailing PE

0

Forward PE

7.13

EV To Revenue

3.611

EV To EBITDA

20.04

52 Week High

69.19

52 Week Low

55.01

50 Day Moving Average

59.83

200 Day Moving Average

64.73

Shares Outstanding

2222110000

Shares Float

2192782000

Shares Short Prior Month

20323800

Short Ratio

1.96

Percent Insiders

0.063

Percent Institutions

75.29

Bristol-Myers stock forecast for this year


Bristol-Myers stock forecast for Jan 2022.
Estimated Average Forecasted Bristol-Myers Price: 61.57. Positive monthly dynamics of the instrument is expected with 4.896% volatility is expected.

Pessimistic forecast: 60.52

Optimistic: 63.63


Bristol-Myers stock forecast for Feb 2022.
Estimated Average Forecasted Bristol-Myers Price: 60.18. Negative monthly dynamics of the instrument is expected with 4.730% volatility is expected.

Pessimistic forecast: 57.99

Optimistic: 60.87


Bristol-Myers stock forecast for Mar 2022.
Estimated Average Forecasted Bristol-Myers Price: 61.34. Positive monthly dynamics of the instrument is expected with 5.107% volatility is expected.

Pessimistic forecast: 59.55

Optimistic: 62.75


Bristol-Myers stock forecast for Apr 2022.
Estimated Average Forecasted Bristol-Myers Price: 61.54. Positive monthly dynamics of the instrument is expected with 6.124% volatility is expected.

Pessimistic forecast: 60.19

Optimistic: 64.11


Bristol-Myers stock forecast for May 2022.
Estimated Average Forecasted Bristol-Myers Price: 63.57. Positive monthly dynamics of the instrument is expected with 4.897% volatility is expected.

Pessimistic forecast: 61.79

Optimistic: 64.97


Bristol-Myers stock forecast for Jun 2022.
Estimated Average Forecasted Bristol-Myers Price: 63.22. Negative monthly dynamics of the instrument is expected with 3.900% volatility is expected.

Pessimistic forecast: 61.69

Optimistic: 64.20


Bristol-Myers stock forecast for Jul 2022.
Estimated Average Forecasted Bristol-Myers Price: 61.52. Negative monthly dynamics of the instrument is expected with 6.091% volatility is expected.

Pessimistic forecast: 60.00

Optimistic: 63.89


Bristol-Myers stock forecast for Aug 2022.
Estimated Average Forecasted Bristol-Myers Price: 58.27. Negative monthly dynamics of the instrument is expected with 5.338% volatility is expected.

Pessimistic forecast: 57.40

Optimistic: 60.64


Bristol-Myers stock forecast for Sep 2022.
Estimated Average Forecasted Bristol-Myers Price: 55.42. Negative monthly dynamics of the instrument is expected with 6.507% volatility is expected.

Pessimistic forecast: 53.86

Optimistic: 57.61


Bristol-Myers stock forecast for Oct 2022.
Estimated Average Forecasted Bristol-Myers Price: 53.59. Negative monthly dynamics of the instrument is expected with 5.656% volatility is expected.

Pessimistic forecast: 52.11

Optimistic: 55.24


Bristol-Myers stock forecast for Nov 2022.
Estimated Average Forecasted Bristol-Myers Price: 53.68. Positive monthly dynamics of the instrument is expected with 5.714% volatility is expected.

Pessimistic forecast: 51.64

Optimistic: 54.77


Bristol-Myers stock forecast for Dec 2022.
Estimated Average Forecasted Bristol-Myers Price: 55.48. Positive monthly dynamics of the instrument is expected with 5.508% volatility is expected.

Pessimistic forecast: 54.44

Optimistic: 57.61



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 127.71 (27.10.2021) -0.33 %
AbbVie Inc.
ABBV 108.4 (27.10.2021) -1.00 %
Aeterna Zentaris Inc.
AEZS 0.5889 (27.10.2021) -4.06 %
Allakos Inc.
ALLK 106.71 (27.10.2021) -4.63 %
Allogene Therapeutics, Inc.
ALLO 15.94 (27.10.2021) -0.50 %
Amgen Inc.
AMGN 206.58 (27.10.2021) -1.01 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.98 (27.10.2021) -1.45 %
Aurora Cannabis Inc.
ACB 6.84 (27.10.2021) -2.70 %
Becton Dickinson and Company
BDX 245 (27.10.2021) -0.55 %
Biogen Inc.
BIIB 259.95 (27.10.2021) -4.12 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 137.1 (27.10.2021) -3.05 %
BioNTech SE
BNTX 278.77 (27.10.2021) -4.66 %
bluebird bio, Inc.
BLUE 22.06 (27.10.2021) 5.30 %
Boston Scientific Corp.
BSX 43.73 (27.10.2021) -1.33 %
Bristol-Myers Squibb Company
BMY 56.49 (27.10.2021) -3.00 %
Canopy Growth Corp.
CGC 12.78 (27.10.2021) -2.96 %
Castle Biosciences, Inc.
CSTL 60.74 (27.10.2021) -1.41 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 250.17 (27.10.2021) 0.70 %
Emergent BioSolutions Inc.
EBS 48.23 (27.10.2021) -4.27 %
Exelixis, Inc.
EXEL 21.3 (27.10.2021) -1.66 %
G1 Therapeutics, Inc.
GTHX 13.39 (27.10.2021) -2.41 %
Gilead Sciences, Inc.
GILD 66.77 (27.10.2021) -1.42 %
GlaxoSmithKline plc
GSK 40.42 (27.10.2021) 0.60 %
GoodRx Holdings, Inc.
GDRX 42.42 (27.10.2021) -4.35 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 64.97 (27.10.2021) -2.37 %
Inovio Pharmaceuticals, Inc.
INO 6.79 (27.10.2021) -0.73 %
Johnson & Johnson
JNJ 163.74 (27.10.2021) -1.21 %
Medtronic plc.
MDT 122.5 (27.10.2021) -1.25 %
Merck & Co., Inc.
MRK 81.54 (27.10.2021) -0.86 %
Moderna, Inc.
MRNA 340.88 (27.10.2021) -1.41 %
Novartis AG
NVS 82.73 (27.10.2021) -2.49 %
Novavax, Inc.
NVAX 141.55 (27.10.2021) 4.86 %
ObsEva SA
OBSV 2.58 (27.10.2021) -3.01 %
OrganiGram Holdings Inc.
OGI 2.24 (27.10.2021) -1.32 %
Pfizer Inc.
PFE 42.97 (27.10.2021) -1.35 %
Regeneron Pharmaceuticals, Inc.
REGN 589.6 (27.10.2021) -0.43 %
Sanofi
SNY 49.57 (27.10.2021) -0.78 %
Schrodinger, Inc.
SDGR 53.73 (27.10.2021) -1.90 %
Senseonics Holdings, Inc.
SENS 3.33 (27.10.2021) -2.63 %
Sorrento Therapeutics, Inc.
SRNE 6.69 (27.10.2021) -0.59 %
Stryker Corp.
SYK 268.5 (27.10.2021) -1.71 %
Sundial Growers Inc.
SNDL 0.6525 (27.10.2021) -1.85 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.93 (27.10.2021) -4.90 %
Thermo Fisher Scientific Inc.
TMO 612.29 (27.10.2021) 0.65 %
Tilray, Inc.
TLRY 10.3 (27.10.2021) -3.83 %
UnitedHealth Group, Inc.
UNH 453.48 (27.10.2021) -0.26 %
Veeva Systems Inc.
VEEV 313.46 (27.10.2021) -2.95 %
Zomedica Corp.
ZOM 0.5 (27.10.2021) -2.84 %
Zynerba Pharmaceuticals, Inc.
ZYNE 3.71 (27.10.2021) -1.33 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.